Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Understanding which assets have the highest returns can guide your investment strategy. Explore various options to enhance your portfolio.
25,689 articlesA record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Anthropic moved to disable access to its Fable 5 and Mythos 5 models after a U.S. export controls directive barred fo...
A wave of new geopolitical risk models is moving war forecasting from niche research into mainstream finance. The shi...
SpaceX opened at $160.95 per share and briefly topped a $2 trillion valuation on debut, then pulled back to more mode...
In the latest quarter, many hedge funds bought stakes in RidgePoint Heavy Equipment, a niche rental firm. The move si...
As clean energy climbs, storage plays a pivotal role. This article breaks down why energy stock soaring today points ...
Ford investors are watching for signs of real momentum beyond headlines. This article breaks down the latest little g...
Florida's housing market remains hot in 2026 as licensing shifts online. This story evaluates eight top online real e...
As August approaches, a key SpaceX catalyst coming could shift the balance for investors. This guide breaks down what...
Rigetti Computing just landed $100 million in CHIPS Act funding. This article breaks down what that means for the com...
With rates stabilizing in the mid-6% range, the housing market braces for a steadier second half of 2026. Pending sal...
Amazon briefly overtook SpaceX as the world's fifth-largest company by market cap. Here are three reasons that leader...